Icon

Accuray Incorporated Stock Analysis and Price Target COMMON STOCK | Medical Devices | NSD

stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 2.66

+0.01 (+0.38)%

USD 0.26B

0.27M

USD 7.50(+181.95%)

N/A

Icon

ARAY

Accuray Incorporated (USD)
COMMON STOCK | NSD
USD 2.66
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.26B

N/A

USD 2.66

Accuray Incorporated Stock Forecast

USD 7.50
(+181.95%)

Based on the Accuray Incorporated stock forecast from 1 analysts, the average analyst target price for Accuray Incorporated is USD 7.50 over the next 12 months. Accuray Incorporated’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Accuray Incorporated is Slightly Bearish, which is based on 5 positive signals and 7 negative signals. At the last closing, Accuray Incorporated’s stock price was USD 2.66. Accuray Incorporated’s stock price has changed by -3.27% over the past week, +3.10% over the past month and +27.27% over the last year.

No recent analyst target price found for Accuray Incorporated
No recent average analyst rating found for Accuray Incorporated

Company Overview Accuray Incorporated

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia P...Read More

https://www.accuray.com

1310 Chesapeake Terrace, Sunnyvale, CA, United States, 94089

1,024

June

USD

USA

Adjusted Closing Price for Accuray Incorporated (ARAY)

Loading...

Unadjusted Closing Price for Accuray Incorporated (ARAY)

Loading...

Share Trading Volume for Accuray Incorporated Shares

Loading...

Compare Performance of Accuray Incorporated Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for ARAY

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Accuray Incorporated (Sector: Medical Devices )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ABL
Abacus Life Inc. -0.04 (-0.56%) USD161.99B 34.62 16.85

ETFs Containing ARAY

Symbol Name ARAY's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Accuray Incorporated (ARAY) Stock

Based on ratings from 1 analysts Accuray Incorporated's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 1 buy, sell and hold ratings.

ARAY stock's dividend yield is 10.10%. Our analysis grades ARAY stock's dividend yield at A. This means that ARAY stock's dividend yield is above 93% of the stocks in the Medical Devices sector in the NSD exchange. Based on this ARAY may be a good dividend stock for its sector.

Based on targets from 1 analysts, the average taret price for ARAY is USD 7.50 over the next 12 months. The maximum analyst target price is USD 7.5 while the minimum anlayst target price is USD 7.5.

ARAY stock's Price/Earning ratio is 77.60. Our analysis grades ARAY stock's Price / Earning ratio at F. This means that ARAY stock's Price/Earning ratio is above 75% of the stocks in the Medical Devices sector in the NSD exchange. Based on this ARAY may be a overvalued for its sector.

The last closing price of ARAY's stock was USD 2.66.

The most recent market capitalization for ARAY is USD 0.26B.

Based on targets from 1 analysts, the average taret price for ARAY is projected at USD 7.50 over the next 12 months. This means that ARAY's stock price may go up by +181.95% over the next 12 months.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...